Category: Unified Patent Court
-
UPC Roundup (1 week): one more injunction and a bunch of new cases, including Michelin v. Goodyear (approximately 100 years after U.S. dispute)
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our March 8, 2025 UPC Roundup. Not much to report on, but we prefer to keep the weekly rhythm. 1. Hurom v. NUC injunction; clarification on jurisdiction for infringement that occurred or started prior to start of…
-
Samsung countersuing ZTE in UPC: two filings from end of February have become discoverable
Context: Before ZTE brought any standard-essential patent (SEP) infringement action against Samsung, the latter fired the first shot by bringing a FRAND (fair, reasonable and non-discriminatory licensing) action in the UK, followed by a SEP-related antitrust case in Frankfurt, Germany as well as a U.S. antitrust and contract lawsuit (March 3, 2025 ip fray article)….
-
UPC Roundup (1 week): CoA upholds preliminary injunction with clarification on competitive harm; more AASIs; and more
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our March 1, 2025 UPC Roundup, which include several interesting decisions at both the Court of Appeal (CoA) and the Court of First Instance (CFI). 1. CoA upholds provisional measures in Syngenta v. Sumi Agro, clarifies competitive…
-
AA licensors win two AASIs in UPC’s Munich Local Division: Dolby, Sun Patent Trust defang Roku’s lawsuit in District of Massachusetts
Context: HP and TCL settled their disputes over HEVC (H.265) video codec patents through an Access Advance pool license last fall (part 2 of an October 30, 2024 ip fray article). Certain cases related to those disputes were pending in the Unified Patent Court (UPC). But certain cases brought by Access Advance licensors Dolby and…
-
Genevant Sciences and Arbutus Biopharma file mRNA vaccine patent infringement lawsuits against Moderna in UPC, Switzerland, Japan, Canada
The companies are seeking monetary relief and injunctions against Moderna’s Spikevax® and mRESVIA® vaccinations, among others, alleging that the company is infringing their lipid composition patents in 30 different countries.
-
UPC Roundup (1 week): case management and cost reimbursement decisions; new judges and cases
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our February 22, 2025 UPC Roundup. An uneventful week at the UPC itself, with far more excitement sparked by a European Court of Justice (ECJ) decision that enables the UPC to order remedies in European Patent Convention (EPC)…
-
A ‘breakthrough’ that may have gone ‘too far’: fallout follows ECJ’s cross-border jurisdiction ruling
European patent attorneys have largely welcomed a European Court of Justice decision allowing courts to rule on the infringement of U.S., UK, and other foreign patents (as well as award damages and injunctions). But those in foreign jurisdictions, such as China, are concerned that the ruling could lead to “significant chaos” and that the court…
-
UPC Roundup (1 week): third anti-antisuit injunction and another preliminary patent injunction after CoA reverses denial
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our February 15, 2025 UPC Roundup. 1. “Obey the law” PI in Abbott v. SiBio after CoA reverses The Hague LD (link to detailed article) Due to technical maintenance that took the UPC longer than expected, the…
-
Nokia obtains anti-antisuit injunctions in fresh lawsuits against Chinese payment terminal maker SUNMI in UPC, Munich, Mannheim
Nokia has obtained two anti-antisuit injunctions in the UPC and the Regional Court of Munich in an ongoing case against Chinese POS vendor SUNMI.
-
Injunctions can be awarded on general terms: UPC’s Court of Appeal grants Abbott PI in glucose monitoring device dispute
Context: On 20 March 2024, Abbott Diabetes Care Inc. filed an application for a preliminary injunction (PI) in the Unified Patent Court’s (UPC) Local Division in The Hague against Chinese medical manufacturer Sibio Technology Limited and its European partner company Umedwings Netherlands. Abbott alleged that Sibio’s GS1 continuous glucose monitor was infringing EP831283. However, last…